Structures by: Chkirate K.
Total: 13
<i>N</i>-{2-[2-(5-Methyl-1<i>H</i>-pyrazol-3-yl)acetamido]phenyl}benzamide monohydrate
C19H18N4O2,H2O
IUCrData (2017) 2, 2 x170251
a=8.4220(3)Å b=10.0410(4)Å c=10.8799(4)Å
α=101.889(2)° β=94.104(2)° γ=90.4020(10)°
<i>trans</i>-Bis(<i>N</i>-{2-[2-(3-methyl-1<i>H</i>-pyrazol-5-yl-κ<i>N</i>^2^)acetamido-κ<i>O</i>]phenyl}benzamide)bis(perchlorato-κ<i>O</i>)copper(II)
C38H36Cl2CuN8O12
IUCrData (2017) 2, 2 x170285
a=8.6572(2)Å b=8.8108(2)Å c=14.2054(3)Å
α=79.4060(10)° β=86.2400(10)° γ=67.8950(10)°
C16H20Cl2CoN4
C16H20Cl2CoN4
New Journal of Chemistry (2020) 44, 6 2210-2221
a=10.6315(8)Å b=9.9746(5)Å c=16.8984(13)Å
α=90° β=90.076(6)° γ=90°
C16H20Cl2N4Zn
C16H20Cl2N4Zn
New Journal of Chemistry (2020) 44, 6 2210-2221
a=21.6975(12)Å b=8.4668(3)Å c=40.556(2)Å
α=90° β=102.999(4)° γ=90°
C32H42Cl4Co2N8O
C32H42Cl4Co2N8O
New Journal of Chemistry (2020) 44, 6 2210-2221
a=8.7970(15)Å b=11.744(2)Å c=19.603(4)Å
α=77.180(5)° β=82.835(6)° γ=74.748(5)°
1-Ethyl-3-phenyl-1,2-dihydroquinoxalin-2-one
C16H14N2O
Acta Crystallographica Section E (2021) 77, 1 18-22
a=9.2572(9)Å b=9.0531(9)Å c=15.0557(14)Å
α=90° β=99.3290(10)° γ=90°
4-[(4-Allyl-2-methoxyphenoxy)methyl]-1-(4-methoxyphenyl)-1<i>H</i>-1,2,3-triazole
C20H21N3O3
Acta Crystallographica Section E (2020) 76, 6 962-966
a=16.212(3)Å b=5.9584(12)Å c=19.450(4)Å
α=90° β=110.537(3)° γ=90°
4-Dichloromethyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-2-one
C10H8Cl2N2O
Acta Crystallographica Section E (2019) 75, 1 33-37
a=12.1783(6)Å b=5.7217(3)Å c=14.8258(7)Å
α=90° β=95.7400(10)° γ=90°
5-Methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidine
C6H6N4
Acta Crystallographica Section E (2018) 74, 12 1833-1837
a=3.7910(2)Å b=18.0092(10)Å c=9.0069(5)Å
α=90° β=101.704(2)° γ=90°
(4<i>Z</i>)-1-Butyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C16H20N2O2
Acta Crystallographica Section E (2018) 74, 11 1669-1673
a=9.1132(6)Å b=12.6676(9)Å c=12.8164(9)Å
α=91.3440(10)° β=99.5370(10)° γ=96.3400(10)°
<i>N</i>-{2-[(<i>E</i>)-(4-Methylbenzylidene)amino]phenyl}-2-(5-methyl-1-<i>H</i>-pyrazol-3-yl)acetamide hemihydrate
C20H20N4O,0.5(H2O)
Acta Crystallographica Section E (2019) 75, 2 154-158
a=11.546(3)Å b=12.564(3)Å c=13.172(3)Å
α=101.991(3)° β=97.535(3)° γ=99.847(3)°
C24H32CL2N8Ni1O4
C24H32CL2N8Ni1O4
Acta Crystallographica Section E (2002) 58, 7 m337-m339
a=12.1520(10)Å b=19.192(2)Å c=13.7970(10)Å
α=90.0000(10)° β=95.9610(10)° γ=90.0000(10)°
C24H34Cl2N8O12Zn0.5
C24H34Cl2N8O12Zn0.5
Zeitschrift für Kristallographie - New Crystal Structures (2001) 216, 4 635-636
a=15.7901(6)Å b=11.5163(4)Å c=20.1992(6)Å
α=90.000(1)° β=154.373(3)° γ=90.000(1)°